Trials / Completed
CompletedNCT01610804
Choroidal Thickness Measurements During Central Serous Chorioretinopathy (CSCR) Treatment
Choroidal Thickness Measurements During CSCR Treatment Applying EDI-OCT Technology
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 18 (actual)
- Sponsor
- University Hospital Regensburg · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine changes in choroidal thickness in patients with Central Serous Chorioretinopathy (CSCR) during the first 3 months after initial diagnosis via Enhanced-Depth-Imaging-Spectral-Domain-Optical-Coherence-Tomography (EDI-OCT). Study hypothesis: Since exudative changes in the choroid seem to constitute the primary pathology of CSCR, changes in choroidal thickness compared to healthy eyes should be present and be visible using EDI-OCT.
Conditions
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2011-11-01
- Completion
- 2012-05-01
- First posted
- 2012-06-04
- Last updated
- 2012-06-04
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01610804. Inclusion in this directory is not an endorsement.